Affymax Inc AFFY:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 03/13/24 EDT
0.0007UNCH (UNCH)
Volume
74
52 week range
0.00 - 0.04
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0007
  • 52 Week High0.04
  • 52 Week High Date07/26/23
  • 52 Week Low0.00
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap26,243.061
  • Shares Out37.49M
  • 10 Day Average Volume991.33
  • Dividend-
  • Dividend Yield-
  • Beta6.05
  • YTD % Change16.67

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0007
  • 52 Week High0.04
  • 52 Week High Date07/26/23
  • 52 Week Low0.00
  • 52 Week Low Date10/13/23
  • Market Cap26,243.061
  • Shares Out37.49M
  • 10 Day Average Volume991.33
  • Dividend-
  • Dividend Yield-
  • Beta6.05
  • YTD % Change16.67

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-0.00
  • EBITDA (TTM)-4.93M
  • ROE (TTM)98.05%
  • Revenue (TTM)41,999.999
  • Gross Margin (TTM)-
  • Net Margin (TTM)6,414.29%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Affymax Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration...
John Orwin
Independent Chairman of the Board
Jonathan Couchman
President, Chief Executive Officer, Director
Mark Thompson
Chief Financial Officer
Grace Shin J.D.
General Counsel
Address
600 Fifth Avenue, 2nd Floor
New York, NY
10020
United States

Top Peers

SYMBOLLASTCHG%CHG
EVFM
Evofem Biosciences Inc
0.02+0.0013+7.0664%
NTII
Neurobiological Technologies Inc
0.00UNCHUNCH
EIGR
Eiger BioPharmaceuticals Inc
5.11UNCHUNCH
SQZB
SQZ Biotechnologies Co
0.0465UNCHUNCH
JAGX
Jaguar Health Inc
0.0694UNCHUNCH